Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

Joseph R. Berger - , University of Kentucky (Author)
Diego Centonze - , University of Rome Tor Vergata (Author)
Giancarlo Comi - , Vita-Salute San Raffaele University (Author)
Christian Confavreux - , Hôpital neurologique et neurochirurgical Pierre Wertheimer (Author)
Gary Cutter - , University of Alabama at Birmingham (Author)
Gavin Giovannoni - , Department of Neurology, The Barts (Author)
Ralf Gold - , Ruhr University Bochum (Author)
Hans Peter Hartung - , Heinrich Heine University Düsseldorf (Author)
Fred Lublin - , Icahn School of Medicine at Mount Sinai (Author)
Augusto Miravalle - , University of Colorado Denver (Author)
Xavier Montalban - , Autonomous University of Barcelona (Author)
Paul O'Connor - , University of Toronto (Author)
Tomas Olsson - , Karolinska Institutet (Author)
Chris H. Polman - , Vrije Universiteit Amsterdam (VU) (Author)
Olaf Stuve - , University of Texas Southwestern Medical Center (Author)
Jerry S. Wolinsky - , University of Texas Health Science Center at Houston (Author)
Tjalf Ziemssen - , Department of Neurology (Author)

PubMed	20818795